Although its role in cancer is still poorly characterized, HIRA has been shown to suppress oncogene-induced neoplasia by activating a senescence phenotype in a mouse model of skin cancer and to block cell cycle progression in S phase in osteosarcoma cells (13, 14). This evidence concerns the gene HIRA and neoplasm.